Antibodies against lysophosphatidylcholine and oxidized LDL in patients with SLE.
- Published in:
- Lupus, 1999, v. 8, n. 2, p. 142, doi. 10.1191/096120399678847434
- By:
- Publication type:
- Article
Works matching IS 09612033 AND DT 1999 AND VI 8 AND IP 2
Results: 15
1
2
Chronic or recurrent headache in patients with systemic lupus erythematosus: a case control study.
- Published in:
- Lupus, 1999, v. 8, n. 2, p. 151
- By:
- Publication type:
- Article
3
Systemic lupus erythematosus complicated by necrotizing fasciitis.
- Published in:
- Lupus, 1999, v. 8, n. 2, p. 157, doi. 10.1191/096120399678847452
- By:
- Publication type:
- Article
4
Anti-phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS?
- Published in:
- Lupus, 1999, v. 8, n. 2, p. 109, doi. 10.1191/096120399678847461
- By:
- Publication type:
- Article
5
β[sub 2] glycoprotein I containing immune-complexes in lupus patients: association with thrombocytopenia and lipoprotein (a) levels.
- Published in:
- Lupus, 1999, v. 8, n. 2, p. 116, doi. 10.1191/096120399678847470
- By:
- Publication type:
- Article
6
The relationship between defects in lymphocyte production of transforming growth factor-β[sub 1] in systemic lupus erythematosus and disease activity or severity.
- Published in:
- Lupus, 1999, v. 8, n. 2, p. 90, doi. 10.1191/096120399678847489
- By:
- Publication type:
- Article
7
Cytokine-mediated down-regulation of B cell activity in SLE: effects of interleukin-2 and transforming growth factor-beta.
- Published in:
- Lupus, 1999, v. 8, n. 2, p. 95, doi. 10.1191/096120399678847498
- By:
- Publication type:
- Article
8
[Anti-β[sub 2] Glycoprotein I—β[sub 2] Glycoprotein I] immune complexes in patients with antiphospholipid syndrome and other autoimmune diseases.
- Published in:
- Lupus, 1999, v. 8, n. 2, p. 121, doi. 10.1191/096120399678847506
- By:
- Publication type:
- Article
9
Nodular regenerative hyperplasia of the liver and antiphospholipid antibodies: report of two cases and review of the literature.
- Published in:
- Lupus, 1999, v. 8, n. 2, p. 160
- By:
- Publication type:
- Article
10
Antiphospholipid antibodies permeabilize and depolarize brain synaptoneurosomes.
- Published in:
- Lupus, 1999, v. 8, n. 2, p. 127, doi. 10.1191/096120399678847524
- By:
- Publication type:
- Article
11
Anticardiolipin and anti-β[sub 2]glycoprotein-I antibodies in patients with systemic lupus erythematosus: Comparison between Colombians and Spaniards.
- Published in:
- Lupus, 1999, v. 8, n. 2, p. 134, doi. 10.1191/096120399678847533
- By:
- Publication type:
- Article
12
Primary subcutaneous nocardial infection in a SLE patient.
- Published in:
- Lupus, 1999, v. 8, n. 2, p. 164, doi. 10.1191/096120399678847542
- By:
- Publication type:
- Article
13
The multi-faceted role of transforming growth factor-beta in systemic lupus erythematosus.
- Published in:
- Lupus, 1999, v. 8, n. 2, p. 87, doi. 10.1191/096120399678847551
- By:
- Publication type:
- Article
14
Synergetic effect between interleukin-1 receptor antagonist allele (IL1RN*2) and MHC class II (DR17,DQ2) in determining susceptibility to systemic lupus erythematosus.
- Published in:
- Lupus, 1999, v. 8, n. 2, p. 103
- By:
- Publication type:
- Article
15
The Antiphospholipid Syndrome and ‘Multiple Sclerosis’.
- Published in:
- 1999
- By:
- Publication type:
- Editorial